Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of Tricuspid Regurgitation on Patients Lives. Exploration of Experience and Impact on a Daily Basis.

NCT05532956 is registered in ClinicalTrials.gov with Gérond'if as lead sponsor.

NCT NCT05532956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05532956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of Tricuspid Regurgitation on Patients Lives. Exploration of Experience and Impact on a Daily Basis.
Lead sponsor
Gérond'if
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2022
Completion date
October 31, 2022
Enrollment
24 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe tricuspid regurgitation medically treated and not operated (without valve replacement or repair)